COMPASS Pathways plc

CMPS


Canadian symbol: CMPS
US symbol: CMPS

Currency in USD

Valuation Measures

Market Cap (intraday) 51.41B
Enterprise Value 31.01B
Trailing P/E N/A
Forward P/E 1-19.32
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)6.29
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7-21.52

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 313.07%
S&P500 52-Week Change 343.61%
52 Week High 361.69
52 Week Low 322.51
50-Day Moving Average 335.68
200-Day Moving Average 342.30

Share Statistics

Avg Vol (3 month) 3465.73k
Avg Vol (10 day) 3449.7k
Shares Outstanding 541.01M
Implied Shares Outstanding 6N/A
Float 22.28M
% Held by Insiders 14.51%
% Held by Institutions 115.61%
Shares Short (Apr. 29, 2021) 41.79M
Short Ratio (Apr. 29, 2021) 43.67
Short % of Float (Apr. 29, 2021) 4N/A
Short % of Shares Outstanding (Apr. 29, 2021) 44.85%
Shares Short (prior month Mar. 30, 2021) 41.61M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.99%
Return on Equity (ttm)-58.84%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -47.04M
Net Income Avi to Common (ttm)-60.33M
Diluted EPS (ttm)-3.55
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)190.33M
Total Cash Per Share (mrq)5.19
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)29.35
Book Value Per Share (mrq)5.47

Cash Flow Statement

Operating Cash Flow (ttm)-41.38M
Levered Free Cash Flow (ttm)-12.26M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Psychedelics News and Psilocybin Investing

Real-time news from hundreds of sources. Never miss the news that matters the most.




Company News Date
CMPS
COMPASS Pathways plc
3 months ago
CMPS
COMPASS Pathways plc
3 months ago
CMPS
COMPASS Pathways plc
3 months ago

Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts4466
Avg. Estimate-0.39-0.4-1.54-1.78
Low Estimate-0.47-0.49-1.89-2.17
High Estimate-0.33-0.32-1.31-1.58
Year Ago EPSN/A-1-3.55-1.54
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts3366
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings HistoryInvalid Date2020-09-292020-12-302021-03-30
EPS Est.N/A-0.56-1.05-0.47
EPS ActualN/A-1-0.52-0.35
DifferenceN/A-0.440.530.12
Surprise %N/A-78.60%50.50%25.50%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.39-0.4-1.54-1.78
7 Days Ago-0.49-0.51-1.82-2.08
30 Days Ago-0.49-0.51-1.82-2.08
60 Days Ago-0.54-0.56-1.9-2.17
90 Days Ago-0.43-0.44-2.97-1.64
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 Days1121
Up Last 30 Days1121
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A1
Growth EstimatesCMPSIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.60.00%N/AN/AN/A
Current Year56.60%N/AN/AN/A
Next Year-15.60%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in USD
Breakdown
4.51%% of Shares Held by All Insider
15.61%% of Shares Held by Institutions
16.35%% of Float Held by Institutions
83Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
Perceptive Advisors Llc1,047,404Dec. 30, 20202.62%49,898,326
Victory Capital Management Inc.649,200Mar. 30, 20211.63%23,903,544
Founders Fund VII Management, LLC557,760Dec. 30, 20201.40%26,571,686
Jefferies Group Inc554,248Dec. 30, 20201.39%26,404,374
Orbimed Advisors LLC.350,000Dec. 30, 20200.88%16,674,000
Acuta Capital Partners LLC319,000Dec. 30, 20200.80%15,197,160
Logos Global Management LP300,000Dec. 30, 20200.75%14,292,000
Falcon Edge Capital, LP250,398Dec. 30, 20200.63%11,928,960
Corriente Advisors, LLC190,000Dec. 30, 20200.48%9,051,600
Susquehanna International Group, LLP165,643Dec. 30, 20200.41%7,891,232

Top Mutual Fund Holders

HolderSharesDate Reported% OutValue
Victory Portfolios-Victory RS Small Cap Growth Fund259,910Dec. 30, 20200.65%12,382,112
USAA Mutual Fund Tr-Science & Technology Fund150,227Jan. 30, 20210.38%6,584,449
Buffalo Small Cap Fund99,895Dec. 30, 20200.25%4,758,997
Advisors Inner Circle Fund III-Chiron Capital Allocation71,408Jan. 30, 20210.18%3,129,812
Victory Portfolios-Victory RS Science & Technology Fund45,310Dec. 30, 20200.11%2,158,568
JNL Series Trust-JNL/Multi Manager Small Cap GrowthFd43,800Dec. 30, 20200.11%2,086,632
Advanced Series Tr-AST Small Cap Growth Opportunities Port24,870Dec. 30, 20200.06%1,184,806
Valic Company I-Small Cap Aggressive Growth Fd23,100Feb. 27, 20210.06%1,042,272
Victory Variable Insurance Funds-Victory RS Small Cap Grw Eq VIP Ser12,350Dec. 30, 20200.03%588,354
AdvisorShares Trust-Advisorshares Vice ETF11,550Apr. 29, 20210.03%419,149
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by COMPASS Pathways plc


Correction: COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care

COMPASS Pathways establishes Centre of Excellence with Sheppard Prattto accelerate research and improve patient experience in mental health careLondon, UK โ€“ 8 January 2021COMPASS Pathways plc (Nasdaq: CMPS) (โ€œCOMPASSโ€), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, is ... Read More...

COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care

COMPASS Pathways establishes Centre of Excellence with Sheppard Prattto accelerate research and improve patient experience in mental health careLondon, UK โ€“ 8 January 2021COMPASS Pathways plc (Nasdaq: CMPS) (โ€œCOMPASSโ€), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, is ... Read More...

COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care

London, UK - 9 November 2020COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has joined the Psychiatry Consortium, an international collaboration to accelerate drug discovery and development in areas of urgent, unmet medical need.The P... Read More...

COMPASS Pathways plc to announce third quarter 2020 financial results on 12 November 2020

London, UK, Nov. 05, 2020 --COMPASS Pathways plc to announce third quarter 2020 financial resultson 12 November 2020London, UK - 5 November 2020COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release finan... Read More...

COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPO

COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPOLondon, UK โ€“ 26 October 2020COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it will ring the Nasdaq Stoc... Read More...
Coming Soon.

Delayed data (1h)


Share this page